Cerner Corporation has recently been selected by North Central Health Care (“NCHC”) in order to implement Cerner’s electronic health record (EHR) at three multi-specialty behavioral health care facilities across Wisconsin. The agreement will enable Cerner to offer physicians, therapists and nurses with near real-time patient information to drive efficiencies, as well as boost care through industry-leading behavioral health technology.
With this agreement, Cerner is likely to strengthen behavioral health solutions. Notably, behavioral health is the scientific study of emotions, behaviors and biology related to a person's mental well-being.
Benefits of Cerner’s Behavioral Health Technology
On the back of Cerner’s foundational EHR, the company’s collaboration with NCHC is likely to help facilitate integrated care throughout its mental and behavioral health services, which include psychiatric, emergency, rehabilitation and much more.
Cerner’s patient portal solution that is available through the HealtheLife portal will enable it to better prepare health systems like NCHC to provide more care options to patients.
Cerner’s behavioral health technology lends support to the clinical and financial needs of inpatient, outpatient and community behavioral health providers throughout the United States.
Recent Collaborations
In May 2020, Cerner collaborated with Hospital IQ — which is an intelligent automation company — to lend support to health systems with predictive analytics in order to boost clinical and operational awareness. With this partnership, Cerner is likely to bolster the already robust healthcare information technology (HCIT) footprint further.
Further, Cerner and Intermountain Healthcare — which is an integrated, not-for-profit health system — made an announcement of a multi-year expansion in February. The expansion reinforces both the organizations’ long-standing commitment toward improvement of safety, quality, and experience of health care for patients as well as caregivers.
Market Prospects
Per a report by Allied Market Research, the global HCIT market is expected to reach $297 billion at a CAGR of 13.2% during the 2016-2022 period. Rise in demand for quality healthcare services and solutions along with patient safety and care, proactive supportive government initiatives, and increase in acceptance of mHealth and telehealth practices are the factors driving the market. Further, growing adoption of smartphones and patient-doctor convenience are contributing to the market’s growth.
Price Performance
This Zacks Rank #3 (Hold) stock has gained 3.3% in a year’s time compared with the industry’s growth of 8.1%.
Key Picks
Some better-ranked stocks from the broader medical space include Aphria Inc. , HMS Holdings Corp. and West Pharmaceutical Services, Inc. (WST - Free Report) . While Aphria and HMS Holdings carry a Zacks Rank #2, West Pharmaceutical sports a Zacks Rank #1 (Strong Buy).You can see the complete list of today’s Zacks #1 Rank stocks here.
Aphria has an estimated long-term earnings growth rate of 24.6%.
HMS Holdings has an estimated long-term earnings growth rate of 11%.
West Pharmaceutical has a projected long-term earnings growth rate of 9.2%.
Zacks Top 10 Stocks for 2020
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?
Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Access Zacks Top 10 Stocks for 2020 today >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Cerner Corporation has recently been selected by North Central Health Care (“NCHC”) in order to implement Cerner’s electronic health record (EHR) at three multi-specialty behavioral health care facilities across Wisconsin. The agreement will enable Cerner to offer physicians, therapists and nurses with near real-time patient information to drive efficiencies, as well as boost care through industry-leading behavioral health technology.
With this agreement, Cerner is likely to strengthen behavioral health solutions. Notably, behavioral health is the scientific study of emotions, behaviors and biology related to a person's mental well-being.
Benefits of Cerner’s Behavioral Health Technology
On the back of Cerner’s foundational EHR, the company’s collaboration with NCHC is likely to help facilitate integrated care throughout its mental and behavioral health services, which include psychiatric, emergency, rehabilitation and much more.
Cerner’s patient portal solution that is available through the HealtheLife portal will enable it to better prepare health systems like NCHC to provide more care options to patients.
Cerner’s behavioral health technology lends support to the clinical and financial needs of inpatient, outpatient and community behavioral health providers throughout the United States.
Recent Collaborations
In May 2020, Cerner collaborated with Hospital IQ — which is an intelligent automation company — to lend support to health systems with predictive analytics in order to boost clinical and operational awareness. With this partnership, Cerner is likely to bolster the already robust healthcare information technology (HCIT) footprint further.
Further, Cerner and Intermountain Healthcare — which is an integrated, not-for-profit health system — made an announcement of a multi-year expansion in February. The expansion reinforces both the organizations’ long-standing commitment toward improvement of safety, quality, and experience of health care for patients as well as caregivers.
Market Prospects
Per a report by Allied Market Research, the global HCIT market is expected to reach $297 billion at a CAGR of 13.2% during the 2016-2022 period. Rise in demand for quality healthcare services and solutions along with patient safety and care, proactive supportive government initiatives, and increase in acceptance of mHealth and telehealth practices are the factors driving the market. Further, growing adoption of smartphones and patient-doctor convenience are contributing to the market’s growth.
Price Performance
This Zacks Rank #3 (Hold) stock has gained 3.3% in a year’s time compared with the industry’s growth of 8.1%.
Key Picks
Some better-ranked stocks from the broader medical space include Aphria Inc. , HMS Holdings Corp. and West Pharmaceutical Services, Inc. (WST - Free Report) . While Aphria and HMS Holdings carry a Zacks Rank #2, West Pharmaceutical sports a Zacks Rank #1 (Strong Buy).You can see the complete list of today’s Zacks #1 Rank stocks here.
Aphria has an estimated long-term earnings growth rate of 24.6%.
HMS Holdings has an estimated long-term earnings growth rate of 11%.
West Pharmaceutical has a projected long-term earnings growth rate of 9.2%.
Zacks Top 10 Stocks for 2020
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?
Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Access Zacks Top 10 Stocks for 2020 today >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on WST - FREE